The Mod GRF 1-29 x5 Bundle provides five vials of this growth hormone releasing hormone (GHRH) analogue for extended laboratory research applications involving endocrine signaling pathways and receptor biology.
Mod GRF 1-29 is a modified analogue of growth hormone releasing hormone (GHRH) that has been widely studied for its interactions with GHRH receptors and associated signaling pathways.
The peptide functions by binding to GHRH receptors located within the pituitary gland, making it a valuable compound for research involving receptor-mediated biological processes and endocrine communication networks.
Researchers continue to investigate the relationship between GHRH receptor activation, growth hormone signaling pathways and broader endocrine regulatory mechanisms.
Because of its unique molecular characteristics and receptor activity, Mod GRF 1-29 remains an important area of scientific investigation in peptide and endocrine research.
Growth-Tech v3: Nano-GRF-8800 is a proprietary compound developed for research involving GHRH receptor activation and endocrine signaling pathways.
Nano-GRF-8800 has been engineered to support laboratory investigation of receptor interactions, hormone signaling mechanisms and peptide-mediated biological processes.
Extensive molecular refinement has been undertaken to support stability, consistency and research performance.
Note: All compounds are intended for laboratory and research purposes only. No statements made on this website or blog have been evaluated by any local or international regulatory body. All products are intended solely for research applications and are not intended to diagnose, treat, cure or prevent any disease. Please refer to our product use and disclaimer for more information.
Mod GRF 1-29 x 5 – Bundle
$355.00
You save
On Pre-Order: Delivery in 10-15 days
Pre-order • Delivered in 7–10 days
Description
The Mod GRF 1-29 x5 Bundle provides five vials of this growth hormone releasing hormone (GHRH) analogue for extended laboratory research applications involving endocrine signaling pathways and receptor biology.
Mod GRF 1-29 is a modified analogue of growth hormone releasing hormone (GHRH) that has been widely studied for its interactions with GHRH receptors and associated signaling pathways.
The peptide functions by binding to GHRH receptors located within the pituitary gland, making it a valuable compound for research involving receptor-mediated biological processes and endocrine communication networks.
Researchers continue to investigate the relationship between GHRH receptor activation, growth hormone signaling pathways and broader endocrine regulatory mechanisms.
Because of its unique molecular characteristics and receptor activity, Mod GRF 1-29 remains an important area of scientific investigation in peptide and endocrine research.
Growth-Tech v3: Nano-GRF-8800
Molecular Formula Derivative: C149H246N44O42
Targets:
GHRH Receptors
Growth Hormone Signaling
Endocrine Regulation
Growth-Tech v3: Nano-GRF-8800 is a proprietary compound developed for research involving GHRH receptor activation and endocrine signaling pathways.
Nano-GRF-8800 has been engineered to support laboratory investigation of receptor interactions, hormone signaling mechanisms and peptide-mediated biological processes.
Extensive molecular refinement has been undertaken to support stability, consistency and research performance.
Note: All compounds are intended for laboratory and research purposes only. No statements made on this website or blog have been evaluated by any local or international regulatory body. All products are intended solely for research applications and are not intended to diagnose, treat, cure or prevent any disease. Please refer to our product use and disclaimer for more information.
Related products
IPAMORELIN BUNDLE
$450.00You save Pre-order
CJC-1295 WITH DAC BUNDLE
$550.00You save Pre-order
BPC BUNDLE
$580.00You save Add to cart